I don't have experience with it - I doubt anyone does - it's their clinical trial. But I can share the experience so far at UCLA where they treat high risk patients with SBRT monotherapy and up to 9 months of adjuvant Lupron (it was optional). They found low toxicity and the addition of Lupron didn't make a difference in toxicity.
/pcnrv.blogspot.com/2017/03/sbrt-for-high-risk-prostate-cancer.htmlBut apalutamide and abiraterone + prednisone have a higher toxicity profile than just Lupron.